Skip to Content
U.S. National Institutes of Health

NCI R43 and R44 Grants Awarded in FY2001 in Response to PAR-99-101, Innovative Technologies for the Molecular Analysis of Cancer: SBIR/STTR Initiative

(PAR-99-101 is no longer an active program announcement. It has been superseded by PAR-01-105, Innovative Technologies for the Molecular Analysis of Cancer: SBIR/STTR.)

Would you like more information?

Abstracts of these funded grants are entered in the CRISP (Computer Retrieval of Information on Scientific Projects) database of federally funded biomedical research projects at http://crisp.cit.nih.gov/. This searchable database can be used to retrieve abstracts by grant number, principal investigator or other search terms. It also contains abstracts for grants funded in earlier fiscal years.

Grant A Bitter
DNA Mismatch Repair Functional Genetic Tests
Bittech, Inc., Agoura Hills, CA

Mark S Chee
Random Arrays for Gene Expression Profiling
Illumina, Inc., San Diego, CA

Sadanand Gite
Novel Technology for the Analysis of Gene Expression
Ambergen, Inc., Boston, MA

Paul H Johnson
Whole Genome Methylation Assay
EpiGenX Pharmaceuticals, Santa Barbara, CA

Alexander A Kogon
Selection of the Best Ligands from Combinatorial Library
Biolinx, LLC, Hagerstown, MD

Steven P Piccoli
Rolling Circle Amplification Analysis of Cervical Cells
Molecular Staging, Inc., New Haven, CT

Chandra Rao
Analysis of Circulating Cancer Cells Early in Disease
Immunicon Corporation, Huntingdon Valley, PA

Shanxiang Shen
Microcantilever Array Device for Protein Profiling
Protiveris, Inc., Rockville, MD

Roberta A Sulk
One Step H. pylori Test--Screening and Individual Assays
CC Technology, Inc., Laramie, WY

Pen-Cheng Wang
2-D Microfluidic Gene Scanner
Calibrant Biosystems, Bethesda, MD

Jiwu Wang
Innovative RNA Profiling in Cancer Cells
Allele Biotech and Pharmaceuticals, San Diego, CA

Catherine E Willett
Assay for Identifying Angiogenic Drug Targets
Phylonix Pharmaceuticals, Inc., Cambridge, MA